KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 95 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,137,131 | +23.4% | 698,741 | 0.0% | 0.27% | +29.0% |
| Q2 2023 | $9,838,273 | -10.2% | 698,741 | -31.4% | 0.21% | +8.2% |
| Q1 2023 | $10,954,659 | -72.1% | 1,018,091 | -61.2% | 0.19% | -76.6% |
| Q4 2022 | $39,306,382 | +4.8% | 2,623,924 | -10.1% | 0.83% | -15.8% |
| Q3 2022 | $37,493,000 | +32.5% | 2,920,023 | 0.0% | 0.99% | +62.4% |
| Q2 2022 | $28,295,000 | -2.5% | 2,920,023 | 0.0% | 0.61% | +0.2% |
| Q1 2022 | $29,025,000 | -15.5% | 2,920,023 | 0.0% | 0.61% | +14.1% |
| Q4 2021 | $34,369,000 | +3.3% | 2,920,023 | 0.0% | 0.53% | +22.1% |
| Q3 2021 | $33,259,000 | -18.2% | 2,920,023 | 0.0% | 0.44% | +3.8% |
| Q2 2021 | $40,676,000 | -24.7% | 2,920,023 | 0.0% | 0.42% | -21.5% |
| Q1 2021 | $54,050,000 | +4.8% | 2,920,023 | 0.0% | 0.53% | +30.2% |
| Q4 2020 | $51,597,000 | +15.3% | 2,920,023 | 0.0% | 0.41% | +20.9% |
| Q3 2020 | $44,735,000 | -28.2% | 2,920,023 | +19.5% | 0.34% | -40.4% |
| Q2 2020 | $62,269,000 | +112.2% | 2,443,833 | +28.9% | 0.57% | +43.7% |
| Q1 2020 | $29,348,000 | +40.0% | 1,895,888 | 0.0% | 0.40% | +51.7% |
| Q4 2019 | $20,969,000 | +31.9% | 1,895,888 | +1.5% | 0.26% | +19.7% |
| Q3 2019 | $15,893,000 | -36.1% | 1,867,622 | +1.7% | 0.22% | -60.8% |
| Q2 2019 | $24,858,000 | -25.0% | 1,835,888 | 0.0% | 0.56% | -39.8% |
| Q1 2019 | $33,156,000 | -15.0% | 1,835,888 | +32.2% | 0.92% | -42.9% |
| Q4 2018 | $39,014,000 | – | 1,388,888 | – | 1.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |